Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 2426 3735 3791 3794
This examiner grants 52% of resolved cases
Examiner SHOSTAK, ANDREY works in Tech Center 3700 and Art Unit 2426. The examiner has handled 422 resolved cases. The allowance rate for these applications is 52.1 percent. The median time to allowance is 1288 days, which provides a benchmark for the expected duration of the prosecution process. This 1288-day figure is a central metric for applicants to use when planning their timelines in this art unit.
The interview lift for this examiner is 61.8 percent. This figure is larger than the 52.1 percent baseline allowance rate. The 61.8 percent lift indicates that cases involving an interview have a higher probability of allowance. This suggests that oral advocacy is a method for resolving issues with this examiner. Practitioners in Art Unit 2426 should prioritize interviews, given the 61.8 percent lift and the 1288-day median, to improve their chances of success in Tech Center 3700.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19002227 | SYSTEM AND METHOD FOR DETERMINING IMPACT ON BODY PART AND RECOMMENDING EXERCISE | Non-Final OA | Samsung Electronics Co., Ltd. |
| 18642153 | Implant Connectivity | Final Rejection | Howmedica Osteonics Corp. |
| 18374245 | ANALYTE MONITORING DEVICE AND METHODS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 19041501 | CARDIAC MONITOR USING GAIT INFORMATION | Non-Final OA | Cardiac Pacemakers, Inc. |
| 17557603 | CONTACTLESS PATIENT MONITORING SYSTEM WITH AUTOMATIC IMAGE IMPROVEMENT | Non-Final OA | Hill-Rom Services, Inc. |
| 18413578 | GLUCOSE LEVEL CHANGE DETECTION IN EYES USING POLARIZED LIGHT | Non-Final OA | Meta Platforms Technologies, LLC |
| 18103665 | CONTACT FORCE SENSOR COMPRISING TUNED AMPLIFIERS | Final Rejection | BIOSENSE WEBSTER (ISRAEL) LTD. |
| 17233206 | PHYSIOLOGICAL ACOUSTIC MONITORING SYSTEM | Non-Final OA | MASIMO CORPORATION |
| 19029581 | GLYCEMIC URGENCY ASSESSMENT AND ALERTS INTERFACE | Non-Final OA | Dexcom, Inc. |
| 18538982 | CONTINUOUS GLUCOSE MONITORING SYSTEM INSIGHT NOTIFICATIONS | Final Rejection | Dexcom, Inc. |
| 18208218 | APPARATUSES, SYSTEMS, AND METHODS OF CONTROLLING SENSOR DEPLOYMENT | Non-Final OA | DexCom, Inc. |
| 18228347 | ACCESSIBILITY DIAGNOSIS FOR COSMETIC APPLICATOR CONFIGURED FOR USERS WITH LIMITED MOBILITY | Final Rejection | L'OREAL |
| 19058735 | BLOOD PRESSURE MEASURING DEVICE | Non-Final OA | OMRON HEALTHCARE Co., Ltd. |
| 17827498 | SPHYGMOMANOMETER | Final Rejection | OMRON HEALTHCARE CO., LTD. |
| 17380694 | MONITORING BASED ON CONTINUOUS INTRACRANIAL EEG ACTIVITY | Non-Final OA | Biogen MA Inc. |
| 18647432 | TISSUE SAMPLE HOLDER WITH ENHANCED FEATURES | Non-Final OA | Devicor Medical Products, Inc. |
| 18635398 | DIABETIC FOOT EXAMINATION DEVICE | Final Rejection | The Research Foundation for the State University of New York |
| 18712459 | PULSE WAVE MEASURING DEVICE | Final Rejection | MINEBEA MITSUMI Inc. |
| 18972757 | BODY ATTACHABLE UNIT FOR CONTINUOUS BLOOD GLUCOSE MEASUREMENT | Non-Final OA | I-SENS, INC. |
| 18407584 | INTRAVASCULAR DEVICES, SYSTEMS, AND METHODS HAVING SEPARATE SECTIONS WITH ENGAGED CORE COMPONENTS | Non-Final OA | PHILIPS IMAGE GUIDED THERAPY CORPORATION |
| 17781738 | INTRAORAL DEVICE | Non-Final OA | Oxford University Innovation Limited |
| 18407501 | iNPH PREDICTION METHOD BASED ON THE VISUAL ODDBALL PARADIGM | Non-Final OA | TIANJIN UNIVERSITY |
| 17429923 | DEVICE FOR SKIN BIOPSY | Non-Final OA | Singapore University of Technology and Design |
| 18614248 | BLOOD HEALTH MONITORING METHOD AND DEVICE FOR DETECTING AN ANALYTE EXCRETED BY HUMAN SKIN | Non-Final OA | Scosche Industries, Inc. |
| 18205598 | BLOOD HEALTH MONITORING METHOD AND DEVICE | Non-Final OA | SCOSCHE INDUSTRIES, INC. |
| 17342753 | STRESS DISORDER TRAINING | Final Rejection | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
| 17319265 | RESILIENCE TRAINING | Final Rejection | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy